Cathie Wood Poly Pid Ltd. Transaction History

Ark Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	SELL	$4.35 - $5.76 $4,611 - $6,105	-1,060 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$3.92 - $6.25 $1.59 Million - $2.53 Million	-405,508 Reduced 99.74%	1,060 $6,000
Q4 2021 Jan 28, 2022	SELL	$5.52 - $8.42 $357,949 - $546,003	-64,846 Reduced 13.76%	406,568 $2.33 Million
Q3 2021 Nov 12, 2021	SELL	$7.05 - $9.48 $944,474 - $1.27 Million	-133,968 Reduced 22.13%	471,414 $3.67 Million
Q2 2021 Aug 05, 2021	BUY	$8.4 - $9.99 $232,134 - $276,073	27,635 Added 4.78%	605,382 $5.48 Million

Q1 2021 May 13, 2021	BUY	$8.92 - $15.5 $3.87 Million - $6.73 Million	434,019 Added 301.97%	577,747 $5.29 Million
Q4 2020 Feb 12, 2021	BUY	$8.89 - $13.5 $918,292 - $1.39 Million	103,295 Added 255.47%	143,728 $1.42 Million
Q3 2020 Oct 30, 2020	BUY	$11.0 - $17.33 $444,763 - $700,703	40,433 New	40,433 $445,000

Ticker PYPD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,551,200
Market Cap $88M
Description
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.